Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

832 recalls, newest first

Class II · Moderate risk

Tizanidine Tablets

Failed Dissolution Specifications; Out of Specification (low) results were obtained.

Terminated Dissolution failure Ascend Laboratories LLC D-0173-2021
Class II · Moderate risk

Cephalexin for Oral Suspension

Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL.

Terminated Impurity / degradation Ascend Laboratories LLC NDC 67877-544-88 D-0185-2021
Class III · Low risk

Fentanyl

Subpotency: Out-of-specification stability test result for low potency was obtained.

Terminated Wrong potency / content SCA Pharmaceuticals D-0147-2021
Class II · Moderate risk

Irinotecan Hydrochloride Injection

CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.

Terminated Failed specification Areva Pharmaceuticals Inc NDC 59923-714-02 D-0270-2021
Class II · Moderate risk

Aripiprazole Tablets

Failed Dissolution Specifications: Out of specification for dissolution.

Terminated Dissolution failure The Harvard Drug Group NDC 0904-6512-04 D-0114-2021
Class II · Moderate risk

Athlete's Foot Cream

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. D-0159-2021
Class II · Moderate risk

TopCare Health

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 36800-495-69 D-0158-2021
Class II · Moderate risk

Best Choice

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. D-0157-2021
Class II · Moderate risk

RiteAid Pharmacy RIngworm Cream

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. D-0156-2021
Class II · Moderate risk

Kroger Jock Itch Cream

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 30142-510-01 D-0155-2021
Class II · Moderate risk

Kroger Athlete's Foot Cream

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 30142-305-01 D-0154-2021
Class II · Moderate risk

Kaiser Permanente Clotrimazole Cream USP

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 0179-8014-30 D-0153-2021
Class II · Moderate risk

Equate Athlete's Foot

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 49035-812-01 D-0151-2021
Class II · Moderate risk

CVS Health Athlete's Foot Cream

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 59779-305-03 D-0150-2021
Class I · High risk

Regenecare Ha

Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.

Terminated Microbial contamination MPM Medical LLC NDC 66977-107-03 D-0118-2021

Recalls by year